Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)
Australia · Delayed Price · Currency is AUD | Market Cap | 22.89B +23.1% |
| Revenue (ttm) | 1.92B +14.2% |
| Net Income | 390.06M +24.2% |
| EPS | 0.64 +24.1% |
| Shares Out | n/a |
| PE Ratio | 60.70 |
| Forward PE | 50.87 |
| Dividend | 0.55 (1.41%) |
| Ex-Dividend Date | Jun 22, 2026 |
| Volume | 635,863 |
| Open | 39.43 |
| Previous Close | 39.60 |
| Day's Range | 38.86 - 39.60 |
| 52-Week Range | 26.51 - 40.15 |
| Beta | 0.88 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 25, 2026 |
About ASX:FPH
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilatio... [Read more]
Financial Performance
In fiscal year 2026, ASX:FPH's revenue was 2.31 billion, an increase of 14.22% compared to the previous year's 2.02 billion. Earnings were 468.50 million, an increase of 24.20%.
Financial numbers in NZD Financial StatementsNews
Fisher & Paykel Healthcare again dominant player in market rise – Market close
The S&P/NZX50 Index closed at 13,749.35, up 57.49 points or 0.42%.
Fisher & Paykel drives NZX higher despite other markets falling – Market close
The S&P/NZX50 Index closed at 13,691.85, up 7.8 points or 0.06%.
NZ sharemarket’s flat spell continues as S&P 500 and Nasdaq hit record highs
Ryman declined to a 16-year low, while Fisher & Paykel Healthcare is at an all-time high.
Sharemarket rebounds 1.1% as Fisher & Paykel Healthcare hits record – Market close
The Warehouse returned to profit with an $11.23m annual net result.
Fisher & Paykel Healthcare Corporation Ltd Annual Shareholders Meeting Transcript
Fisher & Paykel Healthcare Corporation Ltd Annual Shareholders Meeting Transcript
NZ sharemarket up 0.8%, F&P Healthcare leads the way – Market close
The S&P/NZX50 Index closed at 13,992.72, up 110.84 points or 0.8%.
Fisher & Paykel Healthcare Corporation Transcript: AGM 2026
Strong financial growth was reported, with revenue and profit up significantly and dividends increased. Strategic investments in R&D and global manufacturing expansion were highlighted, alongside robust governance and risk management. Shareholders approved all resolutions, with active engagement on remuneration and supply chain issues.
Fisher & Paykel Healthcare Corporation Slides: FY 2026
Fisher & Paykel Healthcare Corporation has posted slides in relation to its FY 2026 quarterly earnings report, which was published on August 24, 2026.
Fisher & Paykel Healthcare upgrades 2027 earnings guidance
Fisher & Paykel Healthcare cites strong hospital demand as a growth driver.
Fisher & Paykel Healthcare Corporation Earnings Call Transcript: H2 2026
Revenue and profit grew strongly in FY 2026, driven by robust hospital hardware and consumables sales, margin expansion, and efficiency gains. FY 2027 guidance anticipates continued growth despite tariff and supply chain headwinds, with ongoing capital investment and innovation momentum.
Fisher & Paykel Healthcare Corporation Annual report: H2 2026
Fisher & Paykel Healthcare Corporation has published its H2 2026 annual report on May 25, 2026.
Fisher & Paykel Healthcare Corporation Slides: H2 2026
Fisher & Paykel Healthcare Corporation has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 25, 2026.
Fisher & Paykel Healthcare Corporation Earnings release: H2 2026
Fisher & Paykel Healthcare Corporation released its H2 2026 earnings on May 25, 2026, summarizing the period's financial results.
Fisher & Paykel Healthcare Corporation Earnings release: Trading update
Fisher & Paykel Healthcare Corporation released its earnings on February 22, 2026, summarizing the period's financial results.
Fisher & Paykel Healthcare Corporation Earnings Call Transcript: H1 2026
First half revenue rose 14% to NZD 1.089 billion and net profit after tax increased 39% to NZD 213 million, with strong growth in both hospital and home care segments. Full-year guidance was raised, driven by FX and margin improvements, though H2 results may moderate due to seasonality and hardware sales variability.
Fisher & Paykel Healthcare Corporation Earnings release: H1 2026
Fisher & Paykel Healthcare Corporation released its H1 2026 earnings on November 25, 2025, summarizing the period's financial results.
Fisher & Paykel Healthcare Corporation Quarterly report: H1 2026
Fisher & Paykel Healthcare Corporation has published its H1 2026 quarterly earnings report on November 25, 2025.
Fisher & Paykel Healthcare Corporation Slides: H1 2026
Fisher & Paykel Healthcare Corporation has posted slides in relation to its H1 2026 quarterly earnings report, which was published on November 25, 2025.